Transparency and the pharmaceutical industry

1 Castellani J. Are clinical trial data shared sufficiently today? Yes. BMJ 2013; 347: f1881. http://dx.doi.org/10.1136/bmj.f1881

2 Song F Parekh S Hooper L Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010; 14: 1–193. http://dx.doi.org/10.3310/hta14080

3 Simes RJ. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986; 4: 1529–41.

4 McCray AT Design Ide NC. of implementation a national clinical trials registry. J Am Med Inform Assoc 2000; 7: 313–23.

5 Prayle AP Hurley MN Smyth AR. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 2012; 344: d7373. http://dx.doi.org/10.1136/bmj.d7373

6 Goldacre B Improving Heneghan C. and auditing , access to clinical trial results. BMJ 2014; 348: g213. http://dx.doi.org/10.1136/bmj.g213